Loading...

Pacific Biosciences of California, Inc. Peer Comparison

Metric Value Ranking
Market Cap $372.5 Million 4/6 CRSP
$3.7B
TWST
$2.8B
NTLA
$968.6M
PACB
$372.5M
EDIT
$98.2M
NVTA
$5.7M
Gross Margin 25% 4/6 NTLA
100%
TWST
45%
NVTA
32%
PACB
25%
EDIT
-100%
CRSP
-100%
Profit Margin -100% 2/6 TWST
-41%
PACB
-100%
NVTA
-100%
EDIT
-100%
NTLA
-100%
CRSP
-100%
EBITDA margin -148% 2/6 TWST
-43%
PACB
-148%
NVTA
-808%
NTLA
-1490%
CRSP
-18294%
EDIT
-101870%
Quarterly Revenue $40.0 Million 3/6 NVTA
$121.2M
TWST
$84.7M
PACB
$40.0M
NTLA
$9.1M
CRSP
$602,000
EDIT
$61,000
Quarterly Earnings -$60.7 Million 2/6 TWST
-$34.7M
PACB
-$60.7M
EDIT
-$62.1M
CRSP
-$85.9M
NTLA
-$135.7M
NVTA
-$942.1M
Quarterly Free Cash Flow -$44.7 Million 1/6 PACB
-$44.7M
EDIT
-$55.5M
NVTA
-$66.9M
NTLA
-$86.1M
CRSP
-$107.1M
TWST
-$0
Trailing 4 Quarters Revenue $173.1 Million 4/6 NVTA
$481.6M
TWST
$313.0M
CRSP
$201.6M
PACB
$173.1M
EDIT
$61.8M
NTLA
$43.1M
Trailing 4 Quarters Earnings -$394.2 Million 4/6 NVTA
$121.2M
TWST
$84.7M
PACB
$40.0M
NTLA
$9.1M
CRSP
$602,000
EDIT
$61,000
Quarterly Earnings Growth 9% 3/6 TWST
25%
CRSP
23%
PACB
9%
NTLA
-11%
EDIT
-38%
NVTA
-213%
Annual Earnings Growth -43% 6/6 NVTA
82%
CRSP
31%
TWST
4%
NTLA
-6%
EDIT
-27%
PACB
-43%
Quarterly Revenue Growth -28% 6/6 TWST
27%
EDIT
0%
CRSP
0%
NVTA
-9%
NTLA
-24%
PACB
-28%
Annual Revenue Growth -13% 5/6 EDIT
613%
TWST
21%
CRSP
-4%
NVTA
-11%
PACB
-13%
NTLA
-18%
Cash On Hand $78.0 Million 6/6 TWST
$226.3M
CRSP
$225.7M
NVTA
$158.0M
NTLA
$120.5M
EDIT
$95.8M
PACB
$78.0M
Short Term Debt $10.7 Million 6/6 NVTA
$21.6M
NTLA
$19.2M
CRSP
$16.9M
EDIT
$16.4M
TWST
$14.8M
PACB
$10.7M
Long Term Debt $910.1 Million 2/6 NVTA
$1.5B
PACB
$910.1M
CRSP
$210.7M
NTLA
$82.4M
TWST
$70.2M
EDIT
$22.1M
PE -1.00 1/6 PACB
-1.00
NVTA
-1.00
EDIT
-1.00
NTLA
-1.00
CRSP
-1.00
TWST
-1.00
PS 2.15 4/6 NTLA
22.48
CRSP
18.33
TWST
8.81
PACB
2.15
EDIT
1.59
NVTA
0.01
PB 0.82 4/6 TWST
5.83
CRSP
1.91
NTLA
1.01
PACB
0.82
EDIT
0.56
NVTA
0.00
PC 4.78 4/6 CRSP
16.38
TWST
12.18
NTLA
8.04
PACB
4.78
EDIT
1.03
NVTA
0.04
Liabilities to Equity 2.20 1/6 PACB
2.20
EDIT
0.87
TWST
0.30
NTLA
0.22
CRSP
0.16
NVTA
0.00
ROA -0.27 2/6 CRSP
-11%
PACB
-27%
TWST
-34%
NTLA
-45%
EDIT
-64%
NVTA
-269%
ROE -0.87 5/6 NVTA
133%
CRSP
-12%
TWST
-44%
NTLA
-54%
PACB
-87%
EDIT
-120%
Current Ratio 1.45 5/6 CRSP
7.13
NTLA
5.57
TWST
4.34
EDIT
2.16
PACB
1.45
NVTA
0.33
Quick Ratio 0.08 6/6 PACB
-1.00
NVTA
-1.00
EDIT
-1.00
NTLA
-1.00
CRSP
-1.00
TWST
-1.00
Long Term Debt to Equity 2.01 1/6 PACB}
2.01
TWST}
0.15
EDIT}
0.13
CRSP}
0.11
NTLA}
0.09
NVTA}
-1.37
Debt to Equity 2.03 1/6 PACB
2.03
EDIT
0.22
TWST
0.18
CRSP
0.12
NTLA
0.11
NVTA
-1.39
Burn Rate 0.78 5/6 TWST
5.50
CRSP
2.29
EDIT
1.43
NTLA
0.84
PACB
0.78
NVTA
0.16
Cash to Cap 0.21 3/6 NVTA
27.58
EDIT
0.98
PACB
0.21
NTLA
0.12
TWST
0.08
CRSP
0.06
CCR 0.74 3/6 CRSP
1.25
EDIT
0.89
PACB
0.74
NTLA
0.63
NVTA
0.07
TWST
EV to EBITDA -20.51 4/6 EDIT}
-0.66
NVTA}
-1.38
NTLA}
-7.00
PACB}
-20.51
CRSP}
-33.58
TWST}
-72.54
EV to Revenue 7.02 4/6 NTLA
22.04
CRSP
18.34
TWST
8.35
PACB
7.02
NVTA
2.82
EDIT
0.66